• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Association of Improved Outcomes and Phosphodiesterase-5 Inhibition During Contemporary LVAD Support: End of the Beginning?

作者信息

Jorde Ulrich P, Saeed Omar

机构信息

Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.

Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.

出版信息

JACC Heart Fail. 2022 Feb;10(2):101-103. doi: 10.1016/j.jchf.2021.10.014.

DOI:10.1016/j.jchf.2021.10.014
PMID:35115083
Abstract
摘要

相似文献

1
Association of Improved Outcomes and Phosphodiesterase-5 Inhibition During Contemporary LVAD Support: End of the Beginning?
JACC Heart Fail. 2022 Feb;10(2):101-103. doi: 10.1016/j.jchf.2021.10.014.
2
Phosphodiesterase-5 Inhibitors and Outcomes During Left Ventricular Assist Device Support: A Systematic Review and Meta-Analysis.磷酸二酯酶-5 抑制剂与左心室辅助装置支持期间的结局：系统评价和荟萃分析。
J Card Fail. 2021 Apr;27(4):477-485. doi: 10.1016/j.cardfail.2020.12.018. Epub 2020 Dec 29.
3
Preimplant Phosphodiesterase-5 Inhibitor Use Is Associated With Higher Rates of Severe Early Right Heart Failure After Left Ventricular Assist Device Implantation.植入前磷酸二酯酶-5 抑制剂的使用与左心室辅助装置植入后严重早期右心衰竭的发生率较高相关。
Circ Heart Fail. 2019 Jun;12(6):e005537. doi: 10.1161/CIRCHEARTFAILURE.118.005537. Epub 2019 Jun 11.
4
Phosphodiesterase-5 Inhibitor Therapy for Left Ventricular Assist Device Patients: More Data, More Questions.用于左心室辅助装置患者的磷酸二酯酶-5抑制剂疗法：更多数据，更多问题。
J Am Heart Assoc. 2020 Jul 21;9(14):e017585. doi: 10.1161/JAHA.120.017585. Epub 2020 Jul 10.
5
Response by Blanton et al to Letter Regarding Article, "Preimplant Phosphodiesterase-5 Inhibitor Use Is Associated With Higher Rates of Severe Early Right Heart Failure After LVAD Implantation: An INTERMACS Analysis".
Circ Heart Fail. 2019 Sep;12(9):e006465. doi: 10.1161/CIRCHEARTFAILURE.119.006465. Epub 2019 Sep 13.
6
Postimplant Phosphodiesterase-5 Inhibitor Use in Centrifugal Flow Left Ventricular Assist Devices.植入后磷酸二酯酶-5抑制剂在离心血流左心室辅助装置中的应用
JACC Heart Fail. 2022 Feb;10(2):89-100. doi: 10.1016/j.jchf.2021.09.008. Epub 2021 Dec 8.
7
Increased bleeding risk with phosphodiesterase-5 inhibitors after left ventricular assist device implantation.左心室辅助装置植入后磷酸二酯酶-5 抑制剂出血风险增加。
ESC Heart Fail. 2021 Aug;8(4):2419-2427. doi: 10.1002/ehf2.13322. Epub 2021 Apr 5.
8
Postimplant Phosphodiesterase Type 5 Inhibitors Use Is Associated With Lower Rates of Thrombotic Events After Left Ventricular Assist Device Implantation.植入后磷酸二酯酶 5 抑制剂的使用与左心室辅助装置植入后血栓事件的发生率降低相关。
J Am Heart Assoc. 2020 Jul 21;9(14):e015897. doi: 10.1161/JAHA.119.015897. Epub 2020 Jul 10.
9
Phosphodiesterase-5 Inhibitor Therapy and Post-Left Ventricular Assist Device Outcomes.磷酸二酯酶-5抑制剂治疗与左心室辅助装置植入术后结局
Circ Heart Fail. 2019 Jun;12(6):e006162. doi: 10.1161/CIRCHEARTFAILURE.119.006162. Epub 2019 Jun 11.
10
Evaluation of Clinical Outcomes with Phosphodiesterase-5 Inhibitor Therapy for Right Ventricular Dysfunction After Left Ventricular Assist Device Implantation.评价磷酸二酯酶-5 抑制剂治疗左心室辅助装置植入后右心室功能障碍的临床结局。
ASAIO J. 2019 Mar/Apr;65(3):264-269. doi: 10.1097/MAT.0000000000000809.

引用本文的文献

1
Post-Implant Phosphodiesterase-5 Inhibitors in Patients with Left Ventricular Assist Device: A Systematic Review and Meta-Analysis.左心室辅助装置患者植入后使用磷酸二酯酶-5抑制剂：系统评价与荟萃分析
J Clin Med. 2022 Oct 11;11(20):5988. doi: 10.3390/jcm11205988.